Melanoma of the Ear Canal and Temporal Bone

  • Paul W. Gidley


Melanoma comprises about 5% of cutaneous malignancies and its incidence is increasing. While the external ear is a common site of melanoma for the head and neck, the ear canal, middle ear, inner ear, and cerebellopontine angle are rare sites for melanoma to occur primarily. These sites can also be involved with metastatic melanoma. This chapter discusses the evaluation and management of melanoma that affects the ear canal and temporal bone.


Melanoma Ear canal Middle ear Cerebellopontine angle Metastatic melanoma Target agents Immune checkpoint inhibitor Radiotherapy 


  1. 1.
    Board PDQATE. Melanoma treatment (PDQ(R)): Health professional version. PDQ cancer information summaries. National Cancer Institute: Bethesda; 2017.Google Scholar
  2. 2.
    Schmerber S, Righini C, Soriano E, et al. [The outcome of treatments for carcinoma of the external auditory canal]. Rev Laryngol Otol Rhinol (Bord). 2005;126(3):165–70.Google Scholar
  3. 3.
    Conley J, Schuller DE. Malignancies of the ear. Laryngoscope. 1976;86(8):1147–63.PubMedPubMedCentralCrossRefGoogle Scholar
  4. 4.
    Altuna Mariezkurrena X, Henriquez Alarcon M, Vea Orte JC, Algaba Guimera J. [Malignant tumors of external ear. Review of cases in 1991-2001]. An Otorrinolaringol Ibero Am. 2003;30(1):83–94.Google Scholar
  5. 5.
    Stang A, Pukkala E, Sankila R, Soderman B, Hakulinen T. Time trend analysis of the skin melanoma incidence of Finland from 1953 through 2003 including 16,414 cases. Int J Cancer. 2006;119(2):380–4.PubMedCrossRefGoogle Scholar
  6. 6.
    Green AC, Kimlin M, Siskind V, Whiteman DC. Hypothesis: hair cover can protect against invasive melanoma on the head and neck (Australia). Cancer Causes Control. 2006;17(10):1263–6.PubMedPubMedCentralCrossRefGoogle Scholar
  7. 7.
    Ravin AG, Pickett N, Johnson JL, Fisher SR, Levin LS, Seigler HF. Melanoma of the ear: treatment and survival probabilities based on 199 patients. Ann Plast Surg. 2006;57(1):70–6.PubMedCrossRefGoogle Scholar
  8. 8.
    Ringborg U, Afzelius LE, Lagerlof B, et al. Cutaneous malignant melanoma of the head and neck. Analysis of treatment results and prognostic factors in 581 patients: a report from the Swedish Melanoma Study Group. Cancer. 1993;71(3):751–8.PubMedCrossRefGoogle Scholar
  9. 9.
    Fisher SR. Cutaneous malignant melanoma of the head and neck. Laryngoscope. 1989;99(8 Pt 1):822–36.PubMedGoogle Scholar
  10. 10.
    Thorn M, Ponten F, Bergstrom R, Sparen P, Adami HO. Clinical and histopathologic predictors of survival in patients with malignant melanoma: a population-based study in Sweden. J Natl Cancer Inst. 1994;86(10):761–9.PubMedCrossRefGoogle Scholar
  11. 11.
    Byers RM, Smith JL, Russell N, Rosenberg V. Malignant melanoma of the external ear. Review of 102 cases. Am J Surg. 1980;140(4):518–21.PubMedCrossRefGoogle Scholar
  12. 12.
    Hawkes JE, Truong A, Meyer LJ. Genetic predisposition to melanoma. Semin Oncol. 2016;43(5):591–7.PubMedCrossRefGoogle Scholar
  13. 13.
    Ozturk O, Baglam T, Uneri C, Kullu S. Primary malignant melanoma of the middle ear mucosa: a case report. Kulak Burun Bogaz Ihtis Derg. 2006;16(2):83–6.PubMedGoogle Scholar
  14. 14.
    Whinney D, Kitchen N, Revesz T, Brookes G. Primary malignant melanoma of the cerebellopontine angle. Otol Neurotol. 2001;22(2):218–22.PubMedCrossRefGoogle Scholar
  15. 15.
    Milbrath MM, Campbell BH, Madiedo G, Janjan NA. Malignant melanoma of the external auditory canal. Am J Clin Oncol. 1998;21(1):28–30.PubMedCrossRefGoogle Scholar
  16. 16.
    Amando Garcia L, Suarez Nieto C, Madrigal Rubiales B, Garcia Garcia J. [External ear melanoma]. Acta Otorrinolaringol Esp. 2003;54(2):89–93.Google Scholar
  17. 17.
    Langman A, Yarington T, Patterson SD. Malignant melanoma of the external auditory canal. Otolaryngol Head Neck Surg. 1996;114(4):645–8.PubMedCrossRefGoogle Scholar
  18. 18.
    Hynes B, Lubynski RA, Hynes B. Malignant melanoma of the external ear canal: a rare case. J Otolaryngol. 2004;33(6):401–3.PubMedCrossRefGoogle Scholar
  19. 19.
    Banerjee AR, Meikle D, Dawes PJ, Deans JA. Malignant melanoma of the external auditory meatus. Clin Oncol (R Coll Radiol). 1993;5(4):255–6.CrossRefGoogle Scholar
  20. 20.
    Kang S, Barnhill RL, Graeme-Cook F, Randolph G, Nadol JB, Sober AJ. Primary malignant melanoma of the external auditory canal: a case report with presentation as an aural polyp. Am J Otol. 1992;13(2):194–6.PubMedGoogle Scholar
  21. 21.
    Shih L, Crabtree JA. Carcinoma of the external auditory canal: an update. Laryngoscope. 1990;100(11):1215-1218.CrossRefGoogle Scholar
  22. 22.
    Sambe S, Kobayashi K, Asakura K, Kataura A. [A case of malignant melanoma in the external auditory canal followed by systemic vasculitis]. Nippon Jibiinkoka Gakkai Kaiho. 1985;88(4):455–62.PubMedCrossRefGoogle Scholar
  23. 23.
    Olariu B, Olariu D, Jianu S, Albastroiu F, Ciuchi V, Laky D. [Malignant melanoma of the external auditory canal treated by cryotherapy]. Rev Chir Oncol Radiol. 1984;29(4):299–311.Google Scholar
  24. 24.
    Urpegui Garcia A, Lahoz Zamarro T, Muniesa Soriano JA, et al. [Malignant melanoma of the middle ear, a rare site]. Acta Otorrinolaringol Esp. 1999;50(7):559–62.Google Scholar
  25. 25.
    Xenellis J, Mountricha A, Maragoudakis P, et al. A histological examination in the cases of initial diagnosis as chronic otitis media with a polypoid mass in the external ear canal. Auris Nasus Larynx. 2011;38(3):325–8.PubMedCrossRefGoogle Scholar
  26. 26.
    Khan I, Mohamad S, Shakeel M, Jaramillo MJ. Aural metastasis from a nasal malignant melanoma: case report with literature review. J Laryngol Otol. 2011;125(12):1290–3.PubMedCrossRefGoogle Scholar
  27. 27.
    Walther EK, Krick T. [Malignant melanoma of the temporal bone]. Laryngorhinootologie. 1993;72(1):48–50.Google Scholar
  28. 28.
    Hannan SA, Parikh A. Malignant melanoma of the external ear canal. Lancet. 2006;368(9548):1680.PubMedCrossRefGoogle Scholar
  29. 29.
    Kazikdas KC, Onal K, Kuehnel TS, Ozturk T. An intradermal nevus of the external auditory meatus. Eur Arch Otorhinolaryngol. 2006;263(3):253–5.PubMedCrossRefGoogle Scholar
  30. 30.
    EL MK Jr, Holmes WF, Harwick R. Primary melanoma of the middle ear. Laryngoscope. 1984;94(11 Pt 1):1459–60.Google Scholar
  31. 31.
    Sherman IW, Swift AC, Haqqani MT. Primary mucosal malignant melanoma of the middle ear. J Laryngol Otol. 1991;105(12):1061–4.PubMedCrossRefGoogle Scholar
  32. 32.
    Banerjee A, Meikle D. Malignant melanoma of the middle ear. J Laryngol Otol. 1992;106(6):581.PubMedCrossRefGoogle Scholar
  33. 33.
    Folz BJ, Niemann AM, Lippert BM, Hauschild A, Werner JA. [Mucous membrane melanomas of the upper aerodigestive tract. An analysis of 34 cases]. Laryngorhinootologie. 1997;76(5):289–94.Google Scholar
  34. 34.
    Oueslati Z, Touati S, Gritli S, et al. [Mucous malignant melanoma of the neck and face. Experience at the Salah Azaiz institute (Tunis)]. Rev Laryngol Otol Rhinol (Bord). 2001;122(4):237–40.Google Scholar
  35. 35.
    Uchida M, Matsunami T. Malignant amelanotic melanoma of the middle ear. Arch Otolaryngol Head Neck Surg. 2001;127(9):1126–8.PubMedCrossRefGoogle Scholar
  36. 36.
    Luo H, Liang JJ, Jiang Y. [Primary malignant melanoma of the middle ear and mastoid: a case report]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2008;43(11):865–6.Google Scholar
  37. 37.
    Curry JM, Kung BC, Willcox TO Jr. Malignant melanoma of the middle ear. Otolaryngol Head Neck Surg. 2007;136(5):856–7.PubMedCrossRefGoogle Scholar
  38. 38.
    Tywonczuk-Szulc M, Kibilda B. Malignant melanoma of the auditory tube. Otolaryngol Pol. 2007;61(3):335–8.PubMedCrossRefGoogle Scholar
  39. 39.
    Racic G, Kurtovic D, Roje Z, Tomic S, Dogas Z. Primary mucosal melanoma of the eustachian tube. Eur Arch Otorhinolaryngol. 2004;261(3):139–42.PubMedCrossRefGoogle Scholar
  40. 40.
    Baek SJ, Song MH, Lim BJ, Lee WS. Mucosal melanoma arising in the eustachian tube. J Laryngol Otol. 2006;120(3):E17.PubMedCrossRefGoogle Scholar
  41. 41.
    Lai CC, Tsay SH, Ho CY. Malignant melanoma of the eustachian tube. J Laryngol Otol. 2001;115(7):567–9.PubMedCrossRefGoogle Scholar
  42. 42.
    Sakaki M, Shek TW, Hirokawa M, et al. Melanotic oncocytic metaplasia of the nasopharynx: a report of seven cases and review of the literature. Virchows Arch. 2004;444(4):345–9.PubMedCrossRefGoogle Scholar
  43. 43.
    Piedra MP, Scheithauer BW, Driscoll CL, Link MJ. Primary melanocytic tumor of the cerebellopontine angle mimicking a vestibular schwannoma. Neurosurgery. 2006;59(1):E206.PubMedCrossRefGoogle Scholar
  44. 44.
    Rodriguez-Zuniga, Milton Jose Max, Pablo Humberto Effio-Iman. Primary cerebellopontine angle melanoma: Case Report and Systematic Review. Polish Ann Med.2017;24(2):268–75. CrossRefGoogle Scholar
  45. 45.
    Kingdom TT, Lalwani AK, Pitts LH. Isolated metastatic melanoma of the cerebellopontine angle: case report. Neurosurgery. 1993;33(1):142–4.PubMedGoogle Scholar
  46. 46.
    Anderson TD, Weber RS, Guerry D, et al. Desmoplastic neurotropic melanoma of the head and neck: the role of radiation therapy. Head Neck. 2002;24(12):1068–71.PubMedCrossRefGoogle Scholar
  47. 47.
    Beenken S, Byers R, Smith JL, Goepfert H, Shallenberger R. Desmoplastic melanoma. Histologic correlation with behavior and treatment. Arch Otolaryngol Head Neck Surg. 1989;115(3):374–9.PubMedCrossRefGoogle Scholar
  48. 48.
    Pathak I, O’Brien CJ, Petersen-Schaeffer K, et al. Do nodal metastases from cutaneous melanoma of the head and neck follow a clinically predictable pattern? Head Neck. 2001;23(9):785–90.PubMedPubMedCentralCrossRefGoogle Scholar
  49. 49.
    O’Brien CJ, McNeil EB, McMahon JD, Pathak I, Lauer CS. Incidence of cervical node involvement in metastatic cutaneous malignancy involving the parotid gland. Head Neck. 2001;23(9):744–8.PubMedCrossRefGoogle Scholar
  50. 50.
    Wick MR. Cutaneous melanoma: a current overview. Semin Diagn Pathol. 2016;33(4):225–41.PubMedCrossRefGoogle Scholar
  51. 51.
    Amaral T, Sinnberg T, Meier F, et al. MAPK pathway in melanoma part II-secondary and adaptive resistance mechanisms to BRAF inhibition. Eur J Cancer. 2017;73:93–101.PubMedCrossRefGoogle Scholar
  52. 52.
    Amann VC, Ramelyte E, Thurneysen S, et al. Developments in targeted therapy in melanoma. Eur J Surg Oncol. 2017;43(3):581–93.PubMedCrossRefGoogle Scholar
  53. 53.
    Wagner JD, Park HM, Coleman JJ 3rd, Love C, Hayes JT. Cervical sentinel lymph node biopsy for melanomas of the head and neck and upper thorax. Arch Otolaryngol Head Neck Surg. 2000;126(3):313–21.PubMedCrossRefGoogle Scholar
  54. 54.
    Carlson GW, Murray DR, Greenlee R, et al. Management of malignant melanoma of the head and neck using dynamic lymphoscintigraphy and gamma probe-guided sentinel lymph node biopsy. Arch Otolaryngol Head Neck Surg. 2000;126(3):433–7.PubMedCrossRefGoogle Scholar
  55. 55.
    Wey PD, De La Cruz C, Goydos JS, Choi ML, Borah GL. Sentinel lymph node mapping in melanoma of the ear. Ann Plast Surg. 1998;40(5):506–9.PubMedCrossRefGoogle Scholar
  56. 56.
    Balch CM, Gershenwald JE, S-J S, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol. 2009;27(36):6199–206.PubMedPubMedCentralCrossRefGoogle Scholar
  57. 57.
    Lens M, Dawes M, Newton-Bishop J, Goodacre T. Tumour thickness as a predictor of occult lymph node metastases in patients with stage I and II melanoma undergoing sentinel lymph node biopsy. Br J Surg. 2002;89(10):1223–7.PubMedCrossRefGoogle Scholar
  58. 58.
    Tardelli E, Mazzarri S, Rubello D, et al. Sentinel lymph node biopsy in cutaneous melanoma: standard and new technical procedures and clinical advances. A systematic review of the literature. Clin Nucl Med. 2016;41(12):e498–507.PubMedCrossRefGoogle Scholar
  59. 59.
    Yang E, Linthicum FH Jr. Metastatic melanoma. Otol Neurotol. 2005;26(4):821–2.PubMedCrossRefGoogle Scholar
  60. 60.
    Adler NR, Haydon A, McLean CA, Kelly JW, Mar VJ. Metastatic pathways in patients with cutaneous melanoma. Pigment Cell Melanoma Res. 2017;30(1):13–27.PubMedCrossRefGoogle Scholar
  61. 61.
    Deroee AF, Joglekar S, Paparella MM. Malignant melanoma metastasis to temporal bone. Otol Neurotol. 2009;30(2):248–9.PubMedCrossRefGoogle Scholar
  62. 62.
    Navarrete CM, Ruah CB, Schachern P, Paparella MM. Normal and metastatic melanin in the temporal bone. Am J Otolaryngol. 1995;16(1):33–9.PubMedCrossRefGoogle Scholar
  63. 63.
    Kojima C, Iino Y, Nakamoto Y, Toriyama M. [Histopathological studies of temporal bones of patients with malignant melanoma]. Nippon Jibiinkoka Gakkai Kaiho. 1997;100(6):655–62.PubMedCrossRefGoogle Scholar
  64. 64.
    Conley J, Juarbe C, Patow CA, Angel MF. Metastatic melanoma to the facial nerve. Plast Reconstr Surg. 1991;87(2):341–5.PubMedCrossRefGoogle Scholar
  65. 65.
    Cohen JV, Tawbi H, Margolin KA, et al. Melanoma central nervous system metastases: current approaches, challenges, and opportunities. Pigment Cell Melanoma Res. 2016;29(6):627–42.PubMedPubMedCentralCrossRefGoogle Scholar
  66. 66.
    Arriaga MA, Lo WW, Brackmann DE. Metastatic melanoma to the cerebellopontine angle. Clinical and imaging characteristics. Arch Otolaryngol Head Neck Surg. 1995;121(9):1052–6.PubMedCrossRefGoogle Scholar
  67. 67.
    Brackmann DE, Doherty JK. CPA melanoma: diagnosis and management. Otol Neurotol. 2007;28(4):529–37.PubMedCrossRefGoogle Scholar
  68. 68.
    Delerue O, Destee A, Devos P. Bilateral metastases in the cerebellopontine angle. J Neurol Neurosurg Psychiatry. 1991;54(6):562.PubMedPubMedCentralCrossRefGoogle Scholar
  69. 69.
    Cervio A, Saadia D, Nogues M, Bas C, Coppola F. Metastatic melanoma within the internal auditory canal: a case report. Am J Otolaryngol. 1999;20(4):263–5.PubMedCrossRefGoogle Scholar
  70. 70.
    Garcia Gonzalez LA, Redondo Ventura F. [Metastases in both internal auditive meatus of nasosinusal melanoma]. An Otorrinolaringol Ibero Am. 2005;32(6):537–44.Google Scholar
  71. 71.
    Jacob A, Brightman RP, Welling DB. Bilateral cerebellopontine angle metastatic melanoma: A case report. Ear Nose Throat J. 2007;86(7):388–90.PubMedGoogle Scholar
  72. 72.
    Yang AS, Bird P. Intracranial metastatic melanoma presenting with bilateral hearing loss. Otol Neurotol. 2009;30(2):243–4.PubMedCrossRefGoogle Scholar
  73. 73.
    Fort M, Guet S, Husheng S, Calitchi E, Belkacemi Y. Role of radiation therapy in melanomas: systematic review and best practice in 2016. Crit Rev Oncol Hematol. 2016;99:362–75.PubMedCrossRefGoogle Scholar
  74. 74.
    Ethun CG, Delman KA. The importance of surgical margins in melanoma. J Surg Oncol. 2016;113(3):339–45.PubMedCrossRefGoogle Scholar
  75. 75.
    O’Brien CJ, Coates AS, Petersen-Schaefer K, et al. Experience with 998 cutaneous melanomas of the head and neck over 30 years. Am J Surg. 1991;162(4):310–4.PubMedCrossRefGoogle Scholar
  76. 76.
    Bonnen MD, Ballo MT, Myers JN, et al. Elective radiotherapy provides regional control for patients with cutaneous melanoma of the head and neck. Cancer. 2004;100(2):383–9.PubMedCrossRefGoogle Scholar
  77. 77.
    Agrawal S, Kane JM, Guadagnolo BA, Kraybill WG, Ballo MT. The benefits of adjuvant radiation therapy after therapeutic lymphadenectomy for clinically advanced, high-risk, lymph node-metastatic melanoma. Cancer. 2009;115(24):5836–44.PubMedCrossRefGoogle Scholar
  78. 78.
    O’Brien CJ, Petersen-Schaefer K, Stevens GN, et al. Adjuvant radiotherapy following neck dissection and parotidectomy for metastatic malignant melanoma. Head Neck. 1997;19(7):589–94.PubMedCrossRefGoogle Scholar
  79. 79.
    Ballo MT, Garden AS, Myers JN, et al. Melanoma metastatic to cervical lymph nodes: can radiotherapy replace formal dissection after local excision of nodal disease? Head Neck. 2005;27(8):718–21.PubMedCrossRefGoogle Scholar
  80. 80.
    Chang DT, Amdur RJ, Morris CG, Mendenhall WM. Adjuvant radiotherapy for cutaneous melanoma: comparing hypofractionation to conventional fractionation. Int J Radiat Oncol Biol Phys. 2006;66(4):1051–5.PubMedCrossRefGoogle Scholar
  81. 81.
    Filippi AR, Fava P, Badellino S, Astrua C, Ricardi U, Quaglino P. Radiotherapy and immune checkpoints inhibitors for advanced melanoma. Radiother Oncol. 2016;120(1):1–12.PubMedCrossRefGoogle Scholar
  82. 82.
    Lens MB, Dawes M. Interferon alfa therapy for malignant melanoma: a systematic review of randomized controlled trials. J Clin Oncol. 2002;20(7):1818–25.PubMedCrossRefGoogle Scholar
  83. 83.
    Eton O, Legha SS, Bedikian AY, et al. Sequential biochemotherapy versus chemotherapy for metastatic melanoma: results from a phase III randomized trial. J Clin Oncol. 2002;20(8):2045–52.PubMedCrossRefGoogle Scholar
  84. 84.
    Xin Y, Huang Q, Zhang P, et al. Meta-analysis of the safety and efficacy of interferon combined with Dacarbazine versus Dacarbazine alone in cutaneous malignant melanoma. Medicine. 2016;95(16):e3406.PubMedPubMedCentralCrossRefGoogle Scholar
  85. 85.
    Pasquali S, Chiarion-Sileni V, Rossi CR, Mocellin S. Immune checkpoint inhibitors and targeted therapies for metastatic melanoma: a network meta-analysis. Cancer Treat Rev. 2017;54:34–42.PubMedCrossRefGoogle Scholar
  86. 86.
    Amaral T, Sinnberg T, Meier F, et al. The mitogen-activated protein kinase pathway in melanoma part I— activation and primary resistance mechanisms to BRAF inhibition. Eur J Cancer. 2017;73:85–92.PubMedCrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Head and Neck SurgeryThe University of Texas M.D. Anderson Cancer CenterHoustonUSA

Personalised recommendations